FASLG and breast carcinoma: A significant difference was identified in the distribution of FASL −844 C/T genotype between patients and controls (χ2 = 7.57, p = 0.022) and the TT genotype showed an increased risk for breast cancer (OR = 2.40; 95% CI = 1.12–5.14; p = 0.024).